Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Reverse genetics Schmallenberg virus vaccine compositions, and methods of use thereof

Reverse genetics Schmallenberg virus vaccine compositions, and methods of use thereof

US Patent 9556419 · Granted Jan 31, 2017

Estimated economic value: $47,481,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof2020
Hendra virus recombinant compositions and uses thereof2019
Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof2018
Recombinant CDV compositions and uses thereof2018
Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vacci2018
Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vacci2017
Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and u2017
Recombinant CDV compositions and uses thereof2016
Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and u2014
Recombinant vaccine against West Nile Virus2013
Vaccine against african horse sickness virus2012
Vaccines against vesicular stomatitis2011